Therefore, HBx and AFB1 mediated COX‐2 up‐regulation was required for MLKL to be recruited to RIP3 for subsequent execution of necroptosis, and COX‐2 could serve as a potential therapeutic target for necrotic cell death‐associated hepatic steatosis. This evidence concerns the gene MLKL and fatty liver disease.